AR003001A1 - Composicion farmaceutica estimuladora de la osteogenesis. - Google Patents

Composicion farmaceutica estimuladora de la osteogenesis.

Info

Publication number
AR003001A1
AR003001A1 ARP960102893A AR10289396A AR003001A1 AR 003001 A1 AR003001 A1 AR 003001A1 AR P960102893 A ARP960102893 A AR P960102893A AR 10289396 A AR10289396 A AR 10289396A AR 003001 A1 AR003001 A1 AR 003001A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
stimulating osteogenesis
composition stimulating
osteogenesis
prophylactic
Prior art date
Application number
ARP960102893A
Other languages
English (en)
Inventor
T Hoshino
H Muranishi
S Taketomi
S Iwasa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AR003001A1 publication Critical patent/AR003001A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Abstract

La presente invención provee una composición farmacéutica que comprende una sustancia estimuladora de la osteogénesis no-péptido y un polímerobiodegradable, la cual puede ser utilizada sin riesgos como un agente profiláctico/terapéuticopara distintas enfermedades óseas (por ejemplo,fracturas de huesos)
ARP960102893A 1995-06-05 1996-06-04 Composicion farmaceutica estimuladora de la osteogenesis. AR003001A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13803695 1995-06-05
JP1168696 1996-01-26

Publications (1)

Publication Number Publication Date
AR003001A1 true AR003001A1 (es) 1998-05-27

Family

ID=26347166

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102893A AR003001A1 (es) 1995-06-05 1996-06-04 Composicion farmaceutica estimuladora de la osteogenesis.

Country Status (11)

Country Link
EP (1) EP0831808A1 (es)
KR (1) KR19990022514A (es)
AR (1) AR003001A1 (es)
AU (1) AU717260B2 (es)
CA (1) CA2221784A1 (es)
HU (1) HUP9802573A3 (es)
NO (1) NO975636L (es)
NZ (1) NZ308658A (es)
RU (1) RU2188011C2 (es)
TW (1) TW420608B (es)
WO (1) WO1996039134A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3868997A (en) 1996-08-26 1998-03-19 Takeda Chemical Industries Ltd. Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
AU4165699A (en) * 1998-06-15 2000-01-05 Takeda Chemical Industries Ltd. Composition for treating cartilage disease
AU5194999A (en) 1998-08-07 2000-02-28 Takeda Chemical Industries Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
EP1105140A2 (en) * 1998-08-12 2001-06-13 Takeda Chemical Industries, Ltd. Benzothiepine compounds as enhancer of cell differentiation induction factor
AU5880801A (en) * 2000-05-23 2001-12-03 Takeda Chemical Industries Ltd. Medicinal compositions containing thiophene derivatives
US6926903B2 (en) 2001-12-04 2005-08-09 Inion Ltd. Resorbable polymer composition, implant and method of making implant
AU2003289444A1 (en) * 2002-12-19 2004-09-28 Yasuo Hatate Agricultural-chemical microcapsule preparation made by oil/water liquid drying and process for producing the same
US9814657B2 (en) 2009-04-27 2017-11-14 Premier Dental Products Company Buffered microencapsulated compositions and methods
JP5960593B2 (ja) 2009-04-27 2016-08-02 プレミア デンタル プロダクツ カンパニー マイクロカプセル化組成物及び組織石灰化の方法
TWI458503B (zh) * 2013-04-22 2014-11-01 Medical & Pharm Ind Tech & Dev 維生素ｋ微球、其製造方法、用途、及藥劑

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69132651T2 (de) * 1990-05-30 2001-10-25 Takeda Chemical Industries Ltd Schwefel enthaltende heterocyclische Verbindungen
EP0769015B1 (en) * 1994-07-04 2001-03-14 Takeda Chemical Industries, Ltd. Phosphonic acid compounds, their production and use
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use

Also Published As

Publication number Publication date
KR19990022514A (ko) 1999-03-25
CA2221784A1 (en) 1996-12-12
AU5845796A (en) 1996-12-24
EP0831808A1 (en) 1998-04-01
NO975636L (no) 1998-01-28
HUP9802573A3 (en) 2000-04-28
AU717260B2 (en) 2000-03-23
NO975636D0 (no) 1997-12-04
WO1996039134A1 (en) 1996-12-12
TW420608B (en) 2001-02-01
RU2188011C2 (ru) 2002-08-27
NZ308658A (en) 1999-10-28
HUP9802573A2 (hu) 1999-09-28

Similar Documents

Publication Publication Date Title
WO2002041837A3 (en) Treatment of mucositis
AR020055A1 (es) Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.
EE04221B1 (et) Östrogeeni kasutamine ravimi valmistamiseks füüsiliste seisundite raviks menopausijärgsetel isikutel
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
HRP20020593B1 (en) Brain, spinal and nerve injury treatment
GT199700009AA (es) Terapia combinada para la osteoporosis
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
ES2060310T3 (es) Utilizacion de la n-miristoil-(s)-fenilalanina para la obtencion de medicamentos destinados al tratamiento de enfermedades que hacen intervenir la miristoilacion.
WO2001041753A3 (en) Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
WO2001078830A3 (en) Photostimulaton treatment apparatus and methods for use
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
ES2181017T3 (es) Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol.
AR003001A1 (es) Composicion farmaceutica estimuladora de la osteogenesis.
ES2180729T3 (es) Tratamiento terapeutico combinado de las patologias hiperproliferantes.
ES2041243T3 (es) Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus.
BR0111024A (pt) Composições e métodos para a terapia e diagnóstico de câncer de mama
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
NZ332412A (en) use of interleuklin-10 for treating or preventing ischemia-reperfusion injury
TR199901385T2 (xx) Piperidin t�revleri.
UA28497A (uk) Спосіб лікування нестабільних переломів дистального кінця променевої кістки
DE9404106U1 (de) Vorrichtung zur gezielten Heilbehandlung von erkrankten Zellen, Organen, Geweben o.dgl.
MD1270F1 (en) Method for treatment of the hand navicular bone pseudarthrosis
UA32314A (uk) Спосіб лікування некротичного панкреатиту